📰 Vivos Method News
Page 4 - Vivos Method News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vivos Method. Real-time updates on events, politics, business and more.
March 3, 2023
Vivos Therapeutics (NASDAQ:VVOS) CEO Kirk Huntsman joined Steve Darling from Proactive to share news the company has announced it has acquired certain U.S....
March 3, 2023
Vivos Therapeutics has expanded its portfolio with the addition of lower-cost products for treating conditions associated with OSA.
January 5, 2023
LITTLETON, Colo., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company...
January 4, 2023
The U.S. Food and Drug Administration gave 510(k) clearance to Vivos Therapeutics' daytime-nighttime obstructive sleep apnea device.
December 16, 2022
Call Scheduled for Tuesday, December 20, 2022 at 5:00 pm ET...
November 28, 2022
Vivos expects to become current on its SEC filings in the coming weeks...
August 9, 2022
Littleton, Colo. (PRWEB) August 09, 2022 -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos”) is excited to announce the fourth annual Breathing Wellness
July 14, 2022
Littleton, Colo. (PRWEB) July 14, 2022 -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) is pleased to announce that it has received multiple Class I clearances by
May 26, 2022
26.05.2022 - HIGHLANDS RANCH, Colo., May 26, 2022 (GLOBE NEWSWIRE) - Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment ... Seite 1